Revitalist Provides Summary of 2021, Reporting Patient Visits of 5,000, a 128% Increase From 2020
Ryan Allway
January 21st, 2022
Psychedelics, Top News
REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to recap the milestones the Company reached in the calendar year 2021. The Company has significantly scaled its operations during 2021, ending the year with seven clinics and providing approximately 5,000 patient treatments which represented a 128% increase year over year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220120005428/en/
(Graphic: Business Wire)
Noteworthy events for Revitalist in 2021 are summarized below under the respective headings. Please note that as a summary, this is not a comprehensive listing of the Company’s material events during each stated period. Complete disclosures of material events can be found on the Company’s SEDAR profile.
Patient Visits and Sales
Patient visits grew extensively in 2021, totaling approximately 5,000, up 128% from 2020. Sales for the year ended December 31, 2021, totaled approximately $2,200,000 (unaudited), representing a 110% increase year over year. Monthly visits are listed in the chart above.
Expansion
Revitalist commenced the year with one clinic under operation and ended with seven clinics across four states in the USA. January 2022 announcements included the opening of an additional clinic in Washington, D.C and the acquisition of clinic assets in Jacksonville, FL bringing the current total to nine clinics in 6 states. In addition, the Company executed agreements during 2021 securing options to open nine additional clinics in the USA for a period of three years. The Company also proudly announced patient coverage with Medicare and other insurance providers during the year as well as multiple strategic collaborations including US Veterans Affairs and clinical study partners.
Revitaland
Revitalist acquired a 60% interest in Revitaland Meta Tech Inc. to expand virtual clinics in the metaverse (“ Revitaland ”). Revitaland virtual clinics will allow patients to work with clinicians who aren’t in the same physical space in real time.
The Metaverse is an expansive network of 3D worlds and simulations that support continuity of identity, objects, history, payments, and entitlements, and can be experienced synchronously by an effectively unlimited number of users, each with an individual sense of presence.
Awards & Publications
Revitalist CEO Kathryn Walker received Microdose’s “Entrepreneur of the Year” award in November 2021 at Wonderland: Miami, the largest psychedelic medicine business event.
Clarus securities published coverage on the Company on October 25, 2021, with a speculative buy rating and a target of $1.50 per share. Revitalist was also featured by Forbes in an article highlighting the Company’s holistic approach to ketamine treatments and the vision of its founder, Kathryn Walker.
Equity Financing
Revitalist successfully raised over $11,000,000 in 2021, with it’s last $3,000,000 financing closing in November 2021 whereby H.C. Wainwright & Co. acted as the exclusive placement agent.
Capital Markets
On August 24, 2021, the Company commenced trading on the Canadian Securities Exchange under the symbol CALM. Shortly thereafter, Revitalist listed on the Frankfurt Stock Exchange and the OTCQB.
Revitalist CEO, Kathryn Walker states, “We are thrilled with the year we had in 2021 as we continued to form relationships with clinicians in the USA, provided 5,000 patient visits, and further optimized our operations to facilitate long-term growth. We ended the year with seven clinics and announced another two recently, bringing the total clinic count to nine. During the calendar year 2021, Revitalist also made several notable accomplishments in the capital markets, including our public listing on the Canadian Securities Exchange and raising over $11,000,000. On behalf of the Revitalist team, I express my utmost gratitude to everybody who contributed to our success over the past year as we continue to deliver exceptional patient care and corporate growth.”
ABOUT REVITALIST LIFESTYLE AND WELLNESS LTD.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here .
Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd
On Behalf of the Board
Kathryn Walker
Chief Executive Officer
Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220120005428/en/
For further information please contact:
Revitalist Lifestyle and Wellness Ltd.
Email: IR@revitalist.com
Tel: (865) 585-8414
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
From the rich soils of Southern Oregon, Kentucky and Colorado, Hemptown USA is growing some of the finest high cannabinoid hemp plants in the world.
THC is an ACMPR Licensed Producer and Canada’s largest supplier of legal Cannabis Genetics.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
